The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Endometrial and ovarian cancers predominately affect women after menopause, and are more frequently observed in developed countries. These are considered to be hormone-dependent cancers, as steroid hormones, and estrogens in particular, have roles in their onset and progression. After the production of estrogens in the ovary has ceased, estrogen synthesis occurs in peripheral tissues. This depends on the cellular uptake of estrone-sulfate and dehydroepiandrosterone-sulfate, as the most important steroid precursors in the plasma of postmenopausal women. The uptake through transporter proteins, such as those of the organic anion-transporting polypeptide (OATP) and organic anion-transporter (OAT) families, is followed by the synthesis and action of estradiol E2. Here, we provide an overview of the current understanding of this intracrine action of steroid hormones, which depends on the availability of the steroid precursors and transmembrane transporters for precursor uptake, along with the enzymes for the synthesis of E2. The data is also provided relating to the selected transmembrane transporters from the OATP, OAT, SLC51, and ABC-transporter families, and the enzymes involved in the E2-generating pathways in cancers of the endometrium and ovary. Finally, we discuss these transporters and enzymes as potential drug targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The G-protein-coupled estrogen receptor GPER in health and disease
Prossnitz, E. R., & Barton, M. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.122 · Cited by 925 · cited 1×
“As genes that encode steroid hormone receptors have several transcripts and splice variants, this brings additional complexity to their mechanisms of action (for review, see Prossnitz and Barton, 2011; Thomas and Gustafsson, 2011; Hattori et al., 2016).”
BackgroundHenderson, B. E., & Feigelson, H. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.427 · Cited by 821
Labrie, F. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90116-a · Cited by 685
Labrie, F., Bélanger, A., Luu-The, V., Labrie, C., Simard, J., Cusan, L., Gomez, J.-L., & Candas, B. (1998) · Steroids · doi:10.1016/s0039-128x(98)00007-5 · Cited by 347
New concepts for an old problem: the diagnosis of endometrial hyperplasia
Sanderson, P. A., Critchley, H. O. D., Williams, A. R. W., Arends, M. J., & Saunders, P. T. K. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw042 · Cited by 323
Labrie, F., Diamond, P., Cusan, L., Gomez, J.-L., Bélanger, A., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4306 · Cited by 292
Sex steroid-producing enzymes in human breast cancer
Suzuki, T., Miki, Y., Nakamura, Y., Moriya, T., Ito, K., Ohuchi, N., & Sasano, H. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00834 · Cited by 182
AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer
Rižner, T. L., Šmuc, T., Rupreht, R., Šinkovec, J., & Penning, T. M. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.10.009 · Cited by 159 · cited 3×
“Across multiple studies, positive immunohistochemical staining for Frontiers in Pharmacology | www.frontiersin.org 9 June 2017 | Volume 8 | Article 346 ABCC4 mRNA β HEC-1A after down-regulation of KLF9 Simmen et al., 2008 ABCG2 mRNA CD+133 Ishikawa cells, Expressed Nakamura et al., 2014 Protein CD+133 Ishikawa cells,…”
BackgroundSelf-citationThe important roles of steroid sulfatase and sulfotransferases in gynecological diseases
Rižner, T. L. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00030 · Cited by 98
Self-citationEvidence of androgen action in endometrial and ovarian cancers
Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0551 · Cited by 73 · cited 1×
“The importance of androgens as etiological factors has been supported also by the expression of the androgen receptor and the presence of androgen-metabolizing enzymes in well and moderately differentiated endometrial cancer (Gibson et al., 2014).”
Background
Research works printed but not linked: 171
- Akhmedkhanov, 2001, Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives, Ann. N. Y. Acad. Sci., 943, 296, 10.1111/j.1749-6632.2001.tb03811.x · DOI · Paper page
- Al Sarakbi, 2006, The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer, Anticancer Res, 26, 4985
- Amant, 2005, Endometrial cancer, Lancet, 366, 491, 10.1016/S0140-6736(05)67063-8 · DOI · Paper page
- Anderson, 2003, Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial, JAMA, 290, 1739, 10.1001/jama.290.13.1739 · DOI · Paper page
- Arlanov, 2016, Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546M as functionally damaging variant, Pharmacogenomics J, 16, 193, 10.1038/tpj.2015.27 · DOI
- Audet-Walsh, 2011, Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics, J. Clin. Endocrinol. Metab, 96, E330, 10.1210/jc.2010-2050 · DOI · Paper page
- Auner, 2010, ABC transporter gene expression in benign and malignant ovarian tissue, Gynecol. Oncol., 117, 198, 10.1016/j.ygyno.2009.10.077 · DOI
- Bagnoli, 2013, Clinicopathological impact of ABCC1/MRP1 and ABCC4/MRP4 in epithelial ovarian carcinoma, Biomed. Res. Int., 2013, 143202, 10.1155/2013/143202 · DOI
- Bai, 2000, Estrogen stimulation of ovarian surface epithelial cell proliferation, In Vitro Cell. Dev. Biol. Anim, 36, 657, 10.1290/1071-2690(2000)036<0657:ESOOSE>2.0.CO;2 · doi:10.1290/1071-2690(2000)036<0657:esoose>2.0.co;2
- Ballatori, 2005, OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia, Hepatology, 42, 1270, 10.1002/hep.20961 · DOI · Paper page
- Ballatori, 2013, The heteromeric organic solute transporter, OSTalpha-OSTbeta/SLC51: a transporter for steroid-derived molecules, Mol. Aspects Med, 34, 683, 10.1016/j.mam.2012.11.005 · DOI · Paper page
- Ballatori, 2008, Ostalpha-Ostbeta is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver, Am. J. Physiol. Gastrointest Liver Physiol, 295, G179, 10.1152/ajpgi.90319.2008 · DOI · Paper page
- Bast, 2011, Molecular approaches to personalizing management of ovarian cancer, Ann. Oncol, 22, viii5, 10.1093/annonc/mdr516 · DOI
- Beral, 2007, Ovarian cancer and hormone replacement therapy in the Million Women Study, Lancet, 369, 1703, 10.1016/S0140-6736(07)60534-0 · DOI · Paper page
- Beral, 2015, Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies, Lancet, 385, 1835, 10.1016/S0140-6736(14)61687-1 · DOI · Paper page
- Binder, 2015, Molecular staging of gynecological cancer: what is the future?, Best Pract. Res. Clin. Obstet. Gynaecol, 29, 776, 10.1016/j.bpobgyn.2015.01.008 · DOI
- Blouin, 2009, Androgen metabolism in adipose tissue: recent advances, Mol. Cell. Endocrinol, 301, 97, 10.1016/j.mce.2008.10.035 · DOI
- Bodo, 2003, The role of multidrug transporters in drug availability, metabolism and toxicity, Toxicol. Lett, 141, 133, 10.1016/S0378-4274(02)00497-6 · DOI · Paper page
- Bogliolo, 2017, The role of fulvestrant in endometrial cancer, Expert Opin. Drug Metab. Toxicol, 13, 537, 10.1080/17425255.2016.1244264 · DOI
- Bogliolo, 2016, Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma, Arch. Gynecol. Obstet, 293, 701, 10.1007/s00404-015-3974-9 · DOI
- Bortfeld, 2006, Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system, Neuroscience, 137, 1247, 10.1016/j.neuroscience.2005.10.025 · DOI
- Brozic, 2008, Inhibitors of 17beta-hydroxysteroid dehydrogenase type 1, Curr. Med. Chem, 15, 137, 10.2174/092986708783330629 · DOI · Paper page
- Burckhardt, 2011, In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy, Handb. Exp. Pharmacol, 201, 29, 10.1007/978-3-642-14541-4_2 · DOI · Paper page
- Caron, 2009, Profiling endogenous serum estrogen and estrogen-glucuronides by liquid chromatography-tandem mass spectrometry, Anal. Chem, 81, 10143, 10.1021/ac9019126 · DOI
- Cerami, 2012, The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov, 2, 401, 10.1158/2159-8290.CD-12-0095 · DOI · Paper page
- Chaudhry, 2009, Resistance to chemotherapy and hormone therapy in endometrial cancer, Endocr. Relat. Cancer, 16, 363, 10.1677/ERC-08-0266 · DOI
- Chay, 2010, ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139, Int. J. Oncol, 37, 399, 10.3892/ijo_00000688 · DOI
- Chen, 2016, Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade, Cancer Lett, 370, 153, 10.1016/j.canlet.2015.10.010 · DOI · Paper page
- Chene, 2014, Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen, Eur. J. Histochem, 58, 2251, 10.4081/ejh.2014.2251 · DOI
- Cho, 2009, Molecular characterization of a new ovarian cancer cell line, YDOV-151, established from mucinous cystadenocarcinoma, Tohoku J. Exp. Med, 218, 129, 10.1620/tjem.218.129 · DOI
- Chura, Estrone sulfatase activity in patients with advanced ovarian cancer, Gynecol. Oncol, 112, 205, 10.1016/j.ygyno.2008.08.037 · DOI
- Chura, Steroid-converting enzymes in human ovarian carcinomas, Mol. Cell. Endocrinol, 301, 51, 10.1016/j.mce.2008.07.015 · DOI
- Clendenen, 2016, Premenopausal circulating androgens and risk of endometrial cancer: results of a prospective study, Horm. Cancer, 7, 178, 10.1007/s12672-016-0258-1 · DOI
- Cole, 2014, Multidrug resistance protein 1 (MRP1, ABCC1), a “multitasking” ATP-binding cassette (ABC) transporter, J. Biol. Chem, 289, 30880, 10.1074/jbc.R114.609248 · DOI · Paper page
- Conrad, 2002, A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance, Pharmacogenetics, 12, 321, 10.1097/00008571-200206000-00008 · DOI
- Cornel, 2017, High mRNA levels of 17beta-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer, Mol. Cell. Endocrinol., 442, 51, 10.1016/j.mce.2016.11.030 · DOI · Paper page
- Cornel, 2012, Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol, J. Clin. Endocrinol. Metab, 97, E591, 10.1210/jc.2011-2994 · DOI · Paper page
- Crawford, 2009, Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition, J. Clin. Endocrinol. Metab, 94, 2945, 10.1210/jc.2009-0386 · DOI
- Cui, 2001, Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6, J. Biol. Chem, 276, 9626, 10.1074/jbc.M004968200 · DOI · Paper page
- Daldorff, 2017, Cotargeting of CYP-19 (aromatase) and emerging, pivotal signalling pathways in metastatic breast cancer, Br. J. Cancer, 116, 10, 10.1038/bjc.2016.405 · DOI
- Diep, 2015, Progesterone action in breast, uterine, and ovarian cancers, J. Mol. Endocrinol, 54, R31, 10.1530/JME-14-0252 · DOI · Paper page
- Domcke, 2013, Evaluating cell lines as tumour models by comparison of genomic profiles, Nat. Commun., 4, 2126, 10.1038/ncomms3126 · DOI · Paper page
- Ee, 2004, Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene, Cancer Res, 64, 1247, 10.1158/0008-5472.CAN-03-3583 · DOI · Paper page
- Ellis, 2015, Selective estrogen receptor modulators in clinical practice: a safety overview, Expert Opin. Drug Saf, 14, 921, 10.1517/14740338.2015.1014799 · DOI
- Elsnerova, 2016, Gene expression of membrane transporters: importance for prognosis and progression of ovarian carcinoma, Oncol. Rep, 35, 2159, 10.3892/or.2016.4599 · DOI
- Ferlay, 2013, GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No.11 (Internet)
- Fogle, 2007, Ovarian androgen production in postmenopausal women, J. Clin. Endocrinol. Metab, 92, 3040, 10.1210/jc.2007-0581 · DOI · Paper page
- Fournier, 2009, Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17β-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12), Mol. Cell. Endocrinol, 301, 142, 10.1016/j.mce.2008.08.027 · DOI
- Fuhrman, 2012, Estrogen metabolism and risk of breast cancer in postmenopausal women, J. Natl. Cancer Inst, 104, 326, 10.1093/jnci/djr531 · DOI · Paper page
- Furihata, 2015, Cancer-type organic anion transporting polypeptide 1B3: current knowledge of the gene structure, expression profile, functional implications and future perspectives, Curr. Drug Metab., 16, 474, 10.2174/1389200216666150812142715 · doi:10.2174/1389200216666150812142715
- Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci. Signal, 6, pl1, 10.1126/scisignal.2004088 · DOI · Paper page
- Giton, 2011, Serum sex steroids measured in middle-aged European and African-Caribbean men by gas chromatography-mass spectrometry, Eur. J. Endocrinol, 165, 917, 10.1530/EJE-11-0551 · DOI
- Gui, 2008, Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3, Eur. J. Pharmacol, 584, 57, 10.1016/j.ejphar.2008.01.042 · DOI · Paper page
- Hagenbuch, 2013, The SLCO (former SLC21) superfamily of transporters, Mol. Aspects Med, 34, 396, 10.1016/j.mam.2012.10.009 · DOI · Paper page
- Haley, 2016, Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease, Oncotarget, 7, 32810, 10.18632/oncotarget.9053 · DOI
- Hampel, 2011, The search for unaffected individuals with Lynch syndrome: do the ends justify the means?, Cancer Prev. Res., 4, 1, 10.1158/1940-6207.CAPR-10-0345 · DOI · Paper page
- Harrelson, 2016, Expanding the view of breast cancer metabolism: promising molecular targets and therapeutic opportunities, Pharmacol. Ther., 167, 60, 10.1016/j.pharmthera.2016.07.014 · DOI
- Hattori, 2016, Human C-terminally truncated ERα variants resulting from the use of alternative exons in the ligand-binding domain, Mol. Cell. Endocrinol., 425, 111, 10.1016/j.mce.2016.01.026 · DOI
- Hevir-Kene, 2015, The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism, Chem. Biol. Interact., 234, 309, 10.1016/j.cbi.2014.11.015 · DOI
- Hewitt, 2016, What's new in estrogen receptor action in the female reproductive tract, J. Mol. Endocrinol, 56, R55, 10.1530/jme-15-0254 · DOI · Paper page
- Higuchi, 2016, Contribution of estrone sulfate to cell proliferation in aromatase inhibitor (AI) -resistant, hormone receptor-positive breast cancer, PLoS ONE, 11, e0155844, 10.1371/journal.pone.0155844 · DOI
- Ho, 2003, Estrogen, progesterone and epithelial ovarian cancer, Reprod. Biol. Endocrinol., 1, 73, 10.1186/1477-7827-1-73 · DOI · Paper page
- Hu, 2005, Expression of estrogen receptors ERalpha and ERbeta in endometrial hyperplasia and adenocarcinoma, Int. J. Gynecol. Cancer, 15, 537, 10.1111/j.1525-1438.2005.15321.x · DOI
- Imai, 2003, Breast cancer resistance protein exports sulfated estrogens but not free estrogens, Mol. Pharmacol, 64, 610, 10.1124/mol.64.3.610 · DOI · Paper page
- Ishikawa, 2009, Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics, J. Exp. Ther. Oncol., 8, 5
- Jasonni, 1984, Estrone sulphate plasma levels in postmenopausal women with and without endometrial cancer, Cancer, 53, 2698, 10.1002/1097-0142(19840615)53:12<2698::AID-CNCR2820531223>3.0.CO;2-O · DOI
- Jenabi, 2015, The effect of body mass index on endometrial cancer: a meta-analysis, Public Health, 129, 872, 10.1016/j.puhe.2015.04.017 · DOI
- Jeon, 2016, Effect of steroid hormones, estrogen and progesterone, on epithelial mesenchymal transition in ovarian cancer development, J. Steroid Biochem. Mol. Biol., 158, 1, 10.1016/j.jsbmb.2016.02.005 · DOI
- Kalliokoski, 2009, Impact of OATP transporters on pharmacokinetics, Br. J. Pharmacol, 158, 693, 10.1111/j.1476-5381.2009.00430.x · DOI · Paper page
- Kandoth, 2013, Integrated genomic characterization of endometrial carcinoma, Nature, 497, 67, 10.1038/nature12113 · DOI · Paper page
- Keefe, 2014, Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry, PLoS ONE, 9, e93805, 10.1371/journal.pone.0093805 · DOI · Paper page
- Key, 2002, Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies, J. Natl. Cancer Inst, 94, 606, 10.1093/jnci/94.8.606 · DOI · Paper page
- Kobayashi, 2005, Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]), J. Pharm. Pharmacol, 57, 573, 10.1211/0022357055966 · DOI · Paper page
- Koepsell, 2013, The SLC22 family with transporters of organic cations, anions and zwitterions, Mol. Aspects Med, 34, 413, 10.1016/j.mam.2012.10.010 · DOI · Paper page
- Kovacsics, 2016, The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions, Expert Opin. Drug Metab. Toxicol., 13, 409, 10.1080/17425255.2017.1253679 · DOI · Paper page
- Kreuzinger, 2015, Molecular characterization of 7 new established cell lines from high grade serous ovarian cancer, Cancer Lett, 362, 218, 10.1016/j.canlet.2015.03.040 · DOI
- Kruh, 2007, ABCC10, ABCC11, and ABCC12, Pflugers Arch, 453, 675, 10.1007/s00424-006-0114-1 · DOI
- Kullak-Ublick, 1998, Dehydroepiandrosterone sulfate (DHEAS): identification of a carrier protein in human liver and brain, FEBS Lett, 424, 173, 10.1016/S0014-5793(98)00168-9 · DOI · Paper page
- Kullak-Ublick, 2001, Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver, Gastroenterology, 120, 525, 10.1053/gast.2001.21176 · DOI · Paper page
- Kunicka, 2014, Importance of ABCC1 for cancer therapy and prognosis, Drug Metab. Rev, 46, 325, 10.3109/03602532.2014.901348 · DOI
- Labrie, 2003, Extragonadal synthesis of sex steroids: intracrinology, Ann. Endocrinol., 64, 95
- Labrie, 2006, Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women, J. Steroid Biochem. Mol. Biol, 99, 182, 10.1016/j.jsbmb.2006.02.004 · DOI · Paper page
- Labrie, 2009, Comparable amounts of sex steroids are made outside the gonads in men and women: strong lesson for hormone therapy of prostate and breast cancer, J. Steroid Biochem. Mol. Biol, 113, 52, 10.1016/j.jsbmb.2008.11.004 · DOI
- Labrie, 2015, Letter to the editor: superior mass spectrometry-based estrogen assays should replace immunoassays, J. Clin. Endocrinol. Metab., 100, L86, 10.1210/jc.2015-2930 · DOI
- Lancaster, 2013, Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeutics, Mol. Cancer Ther, 12, 1537, 10.1158/1535-7163.MCT-12-0926 · DOI
- Langdon, 2017, Endocrine therapy in epithelial ovarian cancer, Expert Rev. Anticancer Ther, 17, 109, 10.1080/14737140.2017.1272414 · DOI
- Lee, 2010, Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach, Carcinogenesis, 31, 1392, 10.1093/carcin/bgq113 · DOI
- Lee, 2005, Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry, J. Biol. Chem, 280, 9610, 10.1074/jbc.M411092200 · DOI · Paper page
- Lee, 2005, Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein, J. Pharmacol. Exp. Ther, 312, 44, 10.1124/jpet.104.073320 · DOI
- Lépine, 2010, Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways, J. Clin. Endocrinol. Metab., 95, 2689, 10.1210/jc.2010-2648 · DOI · Paper page
- Levin, 2011, Minireview: extranuclear steroid receptors: roles in modulation of cell functions, Mol. Endocrinol, 25, 377, 10.1210/me.2010-0284 · DOI · Paper page
- Li, 2014, Role of solute carriers in response to anticancer drugs, Mol. Cell. Ther., 2, 15, 10.1186/2052-8426-2-15 · DOI
- Lukanova, 2004, Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women, Int. J. Cancer, 108, 425, 10.1002/ijc.11529 · DOI · Paper page
- Lurie, 2011, Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium, PLoS ONE, 6, e20703, 10.1371/journal.pone.0020703 · DOI
- Luu-The, 2010, The intracrine sex steroid biosynthesis pathways, Prog. Brain Res., 181, 177, 10.1016/S0079-6123(08)81010-2 · DOI
- Maeda, 2015, Organic anion transporting polypeptide (OATP)1B1 and OATP1B3 as important regulators of the pharmacokinetics of substrate drugs, Biol. Pharm. Bull, 38, 155, 10.1248/bpb.b14-00767 · DOI
- Manna, 2016, Dysregulation of Aromatase in breast, endometrial, and ovarian cancers: an overview of therapeutic strategies, Prog. Mol. Biol. Transl. Sci., 144, 487, 10.1016/bs.pmbts.2016.10.002 · DOI
- Matsumoto, 2014, ABCC11/MRP8 expression in the gastrointestinal tract and a novel role for pepsinogen secretion, Acta Histochem. Cytochem, 47, 85, 10.1267/ahc.13040 · doi:10.1267/ahc.13040
- Mazumdar, 2009, Binary and ternary crystal structure analyses of a novel inhibitor with 17beta-HSD type 1: a lead compound for breast cancer therapy, Biochem. J, 424, 357, 10.1042/BJ20091020 · DOI
- Meyer zu Schwabedissen, 2008, Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer, Cancer Res, 68, 9338, 10.1158/0008-5472.CAN-08-0265 · DOI · Paper page
- Milewich, 1987, In situ steroid sulfatase activity in human epithelial carcinoma cells of vaginal, ovarian, and endometrial origin, J. Clin. Endocrinol. Metab, 65, 164, 10.1210/jcem-65-1-164 · DOI
- Modan, 1998, Cancer incidence in a cohort of infertile women, Am. J. Epidemiol, 147, 1038, 10.1093/oxfordjournals.aje.a009397 · DOI · Paper page
- Modugno, 2012, Hormone response in ovarian cancer: time to reconsider as a clinical target?, Endocr. Relat. Cancer, 19, R255, 10.1530/ERC-12-0175 · DOI
- Mueller, 2015, The regulation of steroid action by sulfation and desulfation, Endocr. Rev., 36, 526, 10.1210/er.2015-1036 · DOI · Paper page
- Murali, 2014, Classification of endometrial carcinoma: more than two types, Lancet Oncol, 15, e268, 10.1016/S1470-2045(13)70591-6 · DOI · Paper page
- Mylonas, 2010, Prognostic significance and clinical importance of estrogen receptor alpha and beta in human endometrioid adenocarcinomas, Oncol. Rep., 24, 385, 10.3892/or_00000871 · DOI
- Nakamura, 2010, Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer Hum, Pathol., 41, 1516, 10.1016/j.humpath.2010.05.006 · doi:10.1016/j.humpath.2010.05.006
- Nakamura, 2014, Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer, Int. J. Oncol, 44, 669, 10.3892/ijo.2013.2230 · doi:10.3892/ijo.2013.2230
- Nozaki, 2007, Characterization of the uptake of organic anion transporter (OAT) 1 and OAT3 substrates by human kidney slices, J. Pharmacol. Exp. Ther, 321, 362, 10.1124/jpet.106.113076 · DOI
- Obaidat, 2012, The expression and function of organic anion transporting polypeptides in normal tissues and in cancer, Annu. Rev. Pharmacol. Toxicol., 52, 135, 10.1146/annurev-pharmtox-010510-100556 · DOI · Paper page
- Ogane, 2013, Prognostic value of organic anion transporting polypeptide 1B3 and copper transporter 1 expression in endometrial cancer patients treated with paclitaxel and carboplatin, Biomed. Res, 34, 143, 10.2220/biomedres.34.143 · DOI
- Okuda, 2001, Steroid sulfatase expression in ovarian clear cell adenocarcinoma: immunohistochemical study, Gynecol. Oncol., 82, 427, 10.1006/gyno.2001.6322 · DOI
- Pan, 2010, Endometrioid ovarian carcinoma benefits from aromatase inhibitors: case report and literature review, Curr. Oncol, 17, 82, 10.3747/co.v17i6.676 · doi:10.3747/co.v17i6.676
- Park, 2008, Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha, Mol. Endocrinol, 22, 2085, 10.1210/me.2007-0512 · DOI · Paper page
- Pathirage, 2006, Expression of aromatase, estrogen receptors, and their coactivators in patients with endometrial cancer, Fertil. Steril, 86, 469, 10.1016/j.fertnstert.2005.12.057 · DOI
- Pautier, 2012, A phase II multicentre randomized open-label study of oral steroid sulphatase (STS) inhibitor irosustat (BN83495) versus megestrol acetate (MA) in women with advanced/recurrent endometrial cancer, AnnalsOncol, 23, 329
- Pearce, 2008, Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis, Br. J. Cancer, 98, 282, 10.1038/sj.bjc.6604170 · DOI
- Pizzagalli, 2003, Identification of steroid sulfate transport processes in the human mammary gland, J. Clin. Endocrinol. Metab., 88, 3902, 10.1210/jc.2003-030174 · DOI · Paper page
- Potischman, 1996, Case-control study of endogenous steroid hormones and endometrial cancer, J. Natl. Cancer Inst, 88, 1127, 10.1093/jnci/88.16.1127 · DOI · Paper page
- Prat, 2015, Staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication of guidelines from the international Federation of Gynecology and Obstetrics (FIGO), Obstet. Gynecol, 126, 171, 10.1097/AOG.0000000000000917 · DOI · Paper page
- Prossnitz, 2008, Estrogen signaling through the transmembrane G protein-coupled receptor GPR30, Annu. Rev. Physiol., 70, 165, 10.1146/annurev.physiol.70.113006.100518 · DOI · Paper page
- Ramalingam, 2016, Morphologic, immunophenotypic, and molecular features of epithelial ovarian cancer, Oncology, 30, 166
- Ren, 2015, Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy, J. Steroid Biochem. Mol. Biol., 150, 54, 10.1016/j.jsbmb.2015.03.010 · DOI · Paper page
- Rižner, 2013, Estrogen biosynthesis, phase I and phase II metabolism, and action in endometrial cancer, Mol. Cell. Endocrinol, 381, 124, 10.1016/j.mce.2013.07.026 · DOI
- Rojas, 2016, Molecular characterization of epithelial ovarian cancer: implications for diagnosis and treatment, Int. J. Mol. Sci., 17, 2113, 10.3390/ijms17122113 · DOI · Paper page
- Romero-Sánchez, 2008, Expression profile of heptahelical putative membrane progesterone receptors in epithelial ovarian tumors, Hum. Pathol, 39, 1026, 10.1016/j.humpath.2007.11.007 · DOI
- Roth, 2012, OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies, Br. J. Pharmacol, 165, 1260, 10.1111/j.1476-5381.2011.01724.x · DOI · Paper page
- Rutherford, 2000, Absence of estrogen receptor-β expression in metastatic ovarian cancer, Obstet. Gynecol., 96, 417, 10.1016/S0029-7844(00)00917-0 · doi:10.1016/s0029-7844(00)00917-0
- Ryan, 2005, Endometrial cancer, Cell Tissue Res, 322, 53, 10.1007/s00441-005-1109-5 · DOI
- Saegusa, 2000, Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium, Jpn. J. Cancer Res, 91, 510, 10.1111/j.1349-7006.2000.tb00975.x · DOI · Paper page
- Sakaguchi, 2002, Expression of oestrogen receptor alpha and beta in uterine endometrial and ovarian cancers, Eur. J. Cancer, 38, S74, 10.1016/S0959-8049(02)00296-4 · DOI
- Samojlik, 1980, Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma, J. Clin. Invest, 65, 602, 10.1172/JCI109705 · DOI
- Sarkadi, 2006, Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system, Physiol. Rev, 86, 1179, 10.1152/physrev.00037.2005 · DOI · Paper page
- Scharl, 2016, Significance of ovarian function suppression in endocrine therapy for breast cancer in pre-menopausal women, Geburtshilfe Frauenheilkd, 76, 516, 10.1055/s-0042-106389 · DOI
- Schinkel, 2003, Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview, Adv. Drug Deliv. Rev, 55, 3, 10.1016/S0169-409X(02)00169-2 · DOI · Paper page
- Secky, 2013, The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors, J. Drug Deliv., 2013, 957605, 10.1155/2013/957605 · DOI
- Setiawan, 2013, Type I and II endometrial cancers: have they different risk factors?, J. Clin. Oncol, 31, 2607, 10.1200/JCO.2012.48.2596 · DOI · Paper page
- Seward, 2003, Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta, J. Biol. Chem, 278, 27473, 10.1074/jbc.M301106200 · DOI · Paper page
- Sharom, 2014, Complex interplay between the p-glycoprotein multidrug efflux pump and the membrane: its role in modulating protein function, Front. Oncol., 4, 41, 10.3389/fonc.2014.00041 · DOI · Paper page
- Simmen, 2008, The Krüppel-like factor 9 (KLF9) network in HEC-1-A endometrial carcinoma cells suggests the carcinogenic potential of dys-regulated KLF9 expression, Reprod. Biol. Endocrinol., 6, 41, 10.1186/1477-7827-6-41 · DOI
- Sinreih, 2013, Altered expression of genes involved in progesterone biosynthesis, metabolism and action in endometrial cancer, Chem. Biol. Interact, 202, 210, 10.1016/j.cbi.2012.11.012 · DOI
- Slot, 2011, Mammalian multidrug-resistance proteins (MRPs), Essays Biochem, 50, 179, 10.1042/bse0500179 · DOI · Paper page
- Smith, 2003, Aromatase inhibitors in breast cancer, N. Engl. J. Med, 348, 2431, 10.1056/NEJMra023246 · DOI · Paper page
- Smuc, 2009, Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer, Mol. Cell. Endocrinol, 301, 74, 10.1016/j.mce.2008.09.019 · DOI
- Smuc, 2006, Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer, Mol. Cell. Endocrinol, 248, 114, 10.1016/j.mce.2005.10.013 · DOI
- Stanway, 2007, Steroid sulfatase: a new target for the endocrine therapy of breast cancer, Oncologist, 12, 370, 10.1634/theoncologist.12-4-370 · DOI · Paper page
- Stieger, 2014, Organic anion-transporting polypeptides, Curr. Top. Membr., 73, 205, 10.1016/B978-0-12-800223-0.00005-0 · DOI · Paper page
- Sugawara, 2004, Expression of enzyme associated with steroid hormone synthesis and local production of steroid hormone in endometrial carcinoma cells, J. Endocrinol, 180, 135, 10.1677/joe.0.1800135 · DOI
- Svoboda, 2011, Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport, Biomed. Pharmacother., 65, 417, 10.1016/j.biopha.2011.04.031 · DOI
- Szakacs, 2008, The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox), Drug Discov. Today, 13, 379, 10.1016/j.drudis.2007.12.010 · DOI · Paper page
- Tamai, 2000, Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family, Biochem. Biophys. Res. Commun, 273, 251, 10.1006/bbrc.2000.2922 · DOI · Paper page
- Tamai, 2001, Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C, Pharm. Res, 18, 1262, 10.1023/A:1013077609227 · DOI · Paper page
- Tashiro, 2014, High expression of organic anion transporter 2 and organic cation transporter 2 is an independent predictor of good outcomes in patients with metastatic colorectal cancer treated with FOLFOX-based chemotherapy, Am. J. Cancer Res, 4, 528
- Thakkar, 2015, Role of organic anion-transporting polypeptides (OATPs) in cancer therapy, AAPS J, 17, 535, 10.1208/s12248-015-9740-x · DOI
- Thomas, 2011, The different roles of ER subtypes in cancer biology and therapy, Nat. Rev. Cancer, 11, 597, 10.1038/nrc3093 · DOI · Paper page
- Thomas, 2015, Estrogen O-sulfamates and their analogues: clinical steroid sulfatase inhibitors with broad potential, J. Steroid Biochem. Mol. Biol., 153, 160, 10.1016/j.jsbmb.2015.03.012 · DOI
- Traboulsi, 2017, Antiestrogens: structure-activity relationships and use in breast cancer treatment, J. Mol. Endocrinol, 58, R15, 10.1530/JME-16-0024 · DOI
- Ugele, 2003, Characterization and identification of steroid sulfate transporters of human placenta, Am. J. Physiol. Endocrinol. Metab, 284, E390, 10.1152/ajpendo.00257.2002 · DOI · Paper page
- Wan, 2016, The levels of the sex hormones are not different between type 1 and type 2 endometrial cancer, Sci. Rep., 6, 39744, 10.1038/srep39744 · DOI
- Ween, 2015, The role of ABC transporters in ovarian cancer progression and chemoresistance, Crit. Rev. Oncol. Hematol, 96, 220, 10.1016/j.critrevonc.2015.05.012 · DOI · Paper page
- Wlcek, 2008, Altered expression of organic anion transporter polypeptide (OATP) genes in human breast carcinoma, Cancer Biol. Ther, 7, 1450, 10.4161/cbt.7.9.6282 · DOI
- Woo, 2010, Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template, J. Med. Chem, 53, 2155, 10.1021/jm901705h · DOI
- Yamaguchi, 2010, Transport of estrone 3-sulfate mediated by organic anion transporter OATP4C1: estrone 3-sulfate binds to the different recognition site for digoxin in OATP4C1, Drug Metab. Pharmacokinet., 25, 314, 10.2133/dmpk.25.314 · doi:10.2133/dmpk.25.314
- Yasui, 2012, Androgen in postmenopausal women, J. Med. Invest, 59, 12, 10.2152/jmi.59.12 · DOI
- Yeramian, 2013, Endometrial carcinoma: molecular alterations involved in tumor development and progression, Oncogene, 32, 403, 10.1038/onc.2012.76 · DOI · Paper page
- Zakharov, 2010, Suppressed expression of type 2 3alpha/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma, Int. J. Clin. Exp. Pathol, 3, 608
- Zannoni, 2013, The expression ratios of estrogen receptor alpha (ERalpha) to estrogen receptor beta1 (ERbeta1) and ERalpha to ERbeta2 identify poor clinical outcome in endometrioid endometrial cancer, Hum. Pathol., 44, 1047, 10.1016/j.humpath.2012.09.007 · DOI
- Zelcer, 2003, Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4), Biochem. J, 371, 361, 10.1042/bj20021886 · DOI · Paper page
- Zhang, 2008, Identification and characterization of ovarian cancer-initiating cells from primary human tumors, Cancer Res, 68, 4311, 10.1158/0008-5472.CAN-08-0364 · DOI · Paper page
- Zhao, 2014, Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer, World J. Clin. Oncol, 5, 248, 10.5306/wjco.v5.i3.248 · DOI
- Zhou, 2014, Anti-tumor effect of Shu-Gan-Liang-Xue decoction in breast cancer is related to the inhibition of aromatase and steroid sulfatase expression, J. Ethnopharmacol, 154, 687, 10.1016/j.jep.2014.04.045 · DOI
Cited by
Endometriosis: Etiology, pathobiology, and therapeutic prospects
Saunders, P. T. K., & Horne, A. W. (2021) · Cell · doi:10.1016/j.cell.2021.04.041 · Cited by 961
Potter, B. V. L. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0045 · Cited by 73
Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders
Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103276 · Cited by 70
Gibson, D. A., Foster, P. A., Simitsidellis, I., Critchley, H. O. D., Kelepouri, O., Collins, F., & Saunders, P. T. K. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0037 · Cited by 10
Metadata
- Authors
- Rižner, T. L., Thalhammer, T., & Özvegy-Laczka, C.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2017-06-19
- Volume
- 8
- Pages
- 346-346
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2625072044
- Cited by
- 40
- References
- 12
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Javna Agencija za Raziskovalno Dejavnost RS (J3-5510)
- Országos Tudományos Kutatási Alapprogramok (109423)
- Magyar Tudományos Akadémia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers. https://app.cochat.ai/papers/10.3389/fphar.2017.00346
- The paper
- Rižner, T. L., Thalhammer, T., & Özvegy-Laczka, C. (2017). The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2017.00346
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.